Renal Anemia Therapeutics Market Report

China Renal Anemia Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 23, 2023
  • PAGES：179
  • REPORT CODE：GMM1751332
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Renal Anemia Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bayer AG

    • BIOCAD

    • Jiangsu Hansoh Pharmaceutical Co, Ltd

    • Intas Pharmaceuticals Ltd

    • Dong-A Socio Group

    • Japan Tobacco Inc

    • Chong Kun Dang Pharmaceutical Corp

    • GlaxoSmithKline Plc

    • CCM Duopharma Biotech Bhd

    • FibroGen, Inc

    • Daiichi Sankyo Company, Limited

    • Eli Lilly and Company

    By Type:

    • MMP-0101

    • MDGN-201

    • DS-1093

    • Others

    • JTZ-951

    • FG-2216

    • EPO-018B

    By Application:

    • Hospital

    • Clinic

    • Research Center

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Renal Anemia Therapeutics Market Overview 2018-2029

    • 1.1 China Renal Anemia Therapeutics Industry Development Overview

    • 1.2 China Renal Anemia Therapeutics Industry Development History

    • 1.3 China Renal Anemia Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Renal Anemia Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of MMP-0101 (2018-2029)

      • 1.4.2 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of MDGN-201 (2018-2029)

      • 1.4.3 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of DS-1093 (2018-2029)

      • 1.4.4 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.5 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of JTZ-951 (2018-2029)

      • 1.4.6 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of FG-2216 (2018-2029)

      • 1.4.7 China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of EPO-018B (2018-2029)

    • 1.5 China Renal Anemia Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.3 China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • 1.6 China Renal Anemia Therapeutics Market Analysis by Region

      • 1.6.1 North China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Renal Anemia Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Renal Anemia Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Renal Anemia Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Renal Anemia Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Renal Anemia Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Renal Anemia Therapeutics Industry Development

    Chapter 3 Renal Anemia TherapeuticsIndustry Chain Analysis

    • 3.1 Renal Anemia Therapeutics Industry Chain

    • 3.2 Renal Anemia Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Renal Anemia Therapeutics Market

    • 3.3 Renal Anemia Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Renal Anemia Therapeutics Market

    Chapter 4 China Renal Anemia Therapeutics Market, by Type

    • 4.1 China Renal Anemia Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Renal Anemia Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Renal Anemia Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Renal Anemia Therapeutics Production Volume and Growth Rate of MMP-0101

      • 4.5.2 China Renal Anemia Therapeutics Production Volume and Growth Rate of MDGN-201

      • 4.5.3 China Renal Anemia Therapeutics Production Volume and Growth Rate of DS-1093

      • 4.5.4 China Renal Anemia Therapeutics Production Volume and Growth Rate of Others

      • 4.5.5 China Renal Anemia Therapeutics Production Volume and Growth Rate of JTZ-951

      • 4.5.6 China Renal Anemia Therapeutics Production Volume and Growth Rate of FG-2216

      • 4.5.7 China Renal Anemia Therapeutics Production Volume and Growth Rate of EPO-018B

    Chapter 5 China Renal Anemia Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Renal Anemia Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Renal Anemia Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Renal Anemia Therapeutics Market Size and Growth Rate of Hospital

      • 5.5.2 China Renal Anemia Therapeutics Market Size and Growth Rate of Clinic

      • 5.5.3 China Renal Anemia Therapeutics Market Size and Growth Rate of Research Center

    Chapter 6 China Renal Anemia Therapeutics Market, by Region

    • 6.1 China Renal Anemia Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Renal Anemia Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Renal Anemia Therapeutics Market Analysis

    • 7.1 North China Renal Anemia Therapeutics Market, by Type

    • 7.2 North China Renal Anemia Therapeutics Market, by Application

    Chapter 8 Central China Renal Anemia Therapeutics Market Analysis

    • 8.1 Central China Renal Anemia Therapeutics Market, by Type

    • 8.2 Central China Renal Anemia Therapeutics Market, by Application

    Chapter 9 South China Renal Anemia Therapeutics Market Analysis

    • 9.1 South China Renal Anemia Therapeutics Market, by Type

    • 9.2 South China Renal Anemia Therapeutics Market, by Application

    Chapter 10 East China Renal Anemia Therapeutics Market Analysis

    • 10.1 East China Renal Anemia Therapeutics Market, by Type

    • 10.2 East China Renal Anemia Therapeutics Market, by Application

    Chapter 11 Northeast China Renal Anemia Therapeutics Market Analysis

    • 11.1 Northeast China Renal Anemia Therapeutics Market, by Type

    • 11.2 Northeast China Renal Anemia Therapeutics Market, by Application

    Chapter 12 Southwest China Renal Anemia Therapeutics Market Analysis

    • 12.1 Southwest China Renal Anemia Therapeutics Market, by Type

    • 12.2 Southwest China Renal Anemia Therapeutics Market, by Application

    Chapter 13 Northwest China Renal Anemia Therapeutics Market Analysis

    • 13.1 Northwest China Renal Anemia Therapeutics Market, by Type

    • 13.2 Northwest China Renal Anemia Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bayer AG

        • 14.1.1 Bayer AG Company Profile

        • 14.1.2 Bayer AG Renal Anemia Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BIOCAD

        • 14.2.1 BIOCAD Company Profile

        • 14.2.2 BIOCAD Renal Anemia Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Jiangsu Hansoh Pharmaceutical Co, Ltd

        • 14.3.1 Jiangsu Hansoh Pharmaceutical Co, Ltd Company Profile

        • 14.3.2 Jiangsu Hansoh Pharmaceutical Co, Ltd Renal Anemia Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Intas Pharmaceuticals Ltd

        • 14.4.1 Intas Pharmaceuticals Ltd Company Profile

        • 14.4.2 Intas Pharmaceuticals Ltd Renal Anemia Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Dong-A Socio Group

        • 14.5.1 Dong-A Socio Group Company Profile

        • 14.5.2 Dong-A Socio Group Renal Anemia Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Japan Tobacco Inc

        • 14.6.1 Japan Tobacco Inc Company Profile

        • 14.6.2 Japan Tobacco Inc Renal Anemia Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Chong Kun Dang Pharmaceutical Corp

        • 14.7.1 Chong Kun Dang Pharmaceutical Corp Company Profile

        • 14.7.2 Chong Kun Dang Pharmaceutical Corp Renal Anemia Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 GlaxoSmithKline Plc

        • 14.8.1 GlaxoSmithKline Plc Company Profile

        • 14.8.2 GlaxoSmithKline Plc Renal Anemia Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 CCM Duopharma Biotech Bhd

        • 14.9.1 CCM Duopharma Biotech Bhd Company Profile

        • 14.9.2 CCM Duopharma Biotech Bhd Renal Anemia Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 FibroGen, Inc

        • 14.10.1 FibroGen, Inc Company Profile

        • 14.10.2 FibroGen, Inc Renal Anemia Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Daiichi Sankyo Company, Limited

        • 14.11.1 Daiichi Sankyo Company, Limited Company Profile

        • 14.11.2 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Eli Lilly and Company

        • 14.12.1 Eli Lilly and Company Company Profile

        • 14.12.2 Eli Lilly and Company Renal Anemia Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Renal Anemia Therapeutics Industry Research Conclusions

    • 15.2 Renal Anemia Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Renal Anemia Therapeutics Industry Market Size (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of MMP-0101 (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of MDGN-201 (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of DS-1093 (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of JTZ-951 (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of FG-2216 (2018-2029)

    • Figure China Renal Anemia Therapeutics Production Volume, Production Value and Growth Rate of EPO-018B (2018-2029)

    • Figure China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Renal Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • Figure North China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Renal Anemia Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Renal Anemia Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Renal Anemia Therapeutics Market Share by Type in 2018

    • Figure China Renal Anemia Therapeutics Market Share by Type in 2023

    • Figure China Renal Anemia Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of MMP-0101 (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of MDGN-201 (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of DS-1093 (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of JTZ-951 (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of FG-2216 (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume and Growth Rate of EPO-018B (2018-2023)

    • Figure China Renal Anemia Therapeutics Market Share by Application in 2018

    • Figure China Renal Anemia Therapeutics Market Share by Application in 2023

    • Figure China Renal Anemia Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Renal Anemia Therapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Renal Anemia Therapeutics Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Renal Anemia Therapeutics Market Size and Growth Rate of Research Center (2018-2023)

    • Table China Renal Anemia Therapeutics Production Volume by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Production Value by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Renal Anemia Therapeutics Production Value Share by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Sales Volume by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Renal Anemia Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Sales Value by Region (2018-2023)

    • Table China Renal Anemia Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Renal Anemia Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table North China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table South China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table East China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Renal Anemia Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Renal Anemia Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Renal Anemia Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Renal Anemia Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table BIOCAD Company Profile

    • Table BIOCAD Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Hansoh Pharmaceutical Co, Ltd Company Profile

    • Table Jiangsu Hansoh Pharmaceutical Co, Ltd Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Intas Pharmaceuticals Ltd Company Profile

    • Table Intas Pharmaceuticals Ltd Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Dong-A Socio Group Company Profile

    • Table Dong-A Socio Group Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Japan Tobacco Inc Company Profile

    • Table Japan Tobacco Inc Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Chong Kun Dang Pharmaceutical Corp Company Profile

    • Table Chong Kun Dang Pharmaceutical Corp Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table CCM Duopharma Biotech Bhd Company Profile

    • Table CCM Duopharma Biotech Bhd Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table FibroGen, Inc Company Profile

    • Table FibroGen, Inc Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company, Limited Company Profile

    • Table Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Renal Anemia Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US